P53AIP1 Activators are a class of chemicals that enhance the function of p53AIP1. These compounds influence various signaling pathways, thereby leading to an increase in the functional activity of p53AIP1. For instance, Nutlin-3 and RG7112, both acting on the MDM2-p53 interaction, lead to the stabilization and activation of p53, which in turn triggers the activation of p53AIP1. In addition, PRIMA-1Met and RITA, both p53 activators, restore the normal function of mutant p53, thereby activating p53AIP1. MI-77301, another MDM2 inhibitor, prevents the MDM2-p53 interaction, leading to p53 stabilization and activation, which can trigger the activation of p53AIP1.
On the other hand, Tenovin-1, a SIRT1 inhibitor, leads to the acetylation and activation of p53, thereby activating p53AIP1. JNJ-26854165 inhibits MDM2, leading to p53 stabilization and activation, which subsequently triggers the activation of p53AIP1. Similarly, AMG 232, a potent MDM2 inhibitor, prevents the MDM2-p53 interaction, leading to p53 stabilization and activation, whichcan trigger the activation of p53AIP1. SRT1720, a selective SIRT1 inhibitor, increases acetylation and activation of p53, thereby activating p53AIP1. Actinonin, a peptide deformylase inhibitor, indirectly activates p53AIP1 by inhibiting the degradation of p53, leading to increased levels of active p53, which in turn activates p53AIP1.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
Nutlin-3 is a potent and selective MDM2 inhibitor. It prevents the MDM2-p53 interaction, leading to stabilization and activation of p53, which in turn triggers the activation of p53AIP1. | ||||||
PRIMA-1MET | 5291-32-7 | sc-361295 sc-361295A | 10 mg 25 mg | $150.00 $319.00 | 5 | |
PRIMA-1Met is a p53 activator that restores the normal function of mutant p53, thereby activating the downstream target p53AIP1. | ||||||
RG-7112 | 939981-39-2 | sc-507292 | 10 mg | $520.00 | ||
RG7112 is an MDM2 antagonist that inhibits the MDM2-p53 interaction, leading to the stabilization and activation of p53, which can activate p53AIP1. | ||||||
p53 Activator III, RITA | 213261-59-7 | sc-202753 sc-202753A sc-202753B sc-202753C | 1 mg 10 mg 100 mg 500 mg | $110.00 $268.00 $1533.00 $5103.00 | 9 | |
RITA is a p53 activator that binds to p53 and inhibits its interaction with MDM2, leading to p53 stabilization and subsequent activation of p53AIP1. | ||||||
JNJ 26854165 | 881202-45-5 | sc-364514 sc-364514A | 5 mg 25 mg | $168.00 $566.00 | ||
JNJ-26854165 inhibits MDM2, leading to p53 stabilization and activation, which subsequently triggers the activation of p53AIP1. | ||||||
SRT1720 | 1001645-58-4 | sc-364624 sc-364624A | 5 mg 10 mg | $193.00 $357.00 | 13 | |
SRT1720 is a selective SIRT1 inhibitor that increases acetylation and activation of p53, thereby activating p53AIP1. | ||||||
Actinonin | 13434-13-4 | sc-201289 sc-201289B | 5 mg 10 mg | $160.00 $319.00 | 3 | |
Actinonin is a peptide deformylase inhibitor. It indirectly activates p53AIP1 by inhibiting the degradation of p53, leading to increased levels of active p53, which in turn activates p53AIP1. |